VGLL3 and non-Hodgkin lymphoma: Several transcription factors from the TEAD family which are downstream effectors of the Hippo pathway, and for which VGLL3 is a cofactor, are also significantly different between future NHL and controls (hyper-methylated in the future-NHL/high-epiTOC).